Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for HeartSciences (HSCSW) over the last 4 years, with Q4 2025 value amounting to -$15770.0.

  • HeartSciences' Cash from Investing Activities fell 16994.18% to -$15770.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$40097.0, marking a year-over-year increase of 6794.39%. This contributed to the annual value of -$30188.0 for FY2025, which is 7590.18% up from last year.
  • HeartSciences' Cash from Investing Activities amounted to -$15770.0 in Q4 2025, which was down 16994.18% from -$814.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Cash from Investing Activities ranged from a high of -$814.0 in Q3 2025 and a low of -$69228.0 during Q2 2024
  • Over the past 4 years, HeartSciences' median Cash from Investing Activities value was -$7247.0 (recorded in 2022), while the average stood at -$14642.4.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 131772.85% in 2024, then surged by 8871.55% in 2025.
  • Quarter analysis of 4 years shows HeartSciences' Cash from Investing Activities stood at -$7247.0 in 2022, then skyrocketed by 73.06% to -$1952.0 in 2023, then crashed by 199.28% to -$5842.0 in 2024, then plummeted by 169.94% to -$15770.0 in 2025.
  • Its Cash from Investing Activities was -$15770.0 in Q4 2025, compared to -$814.0 in Q3 2025 and -$7812.0 in Q2 2025.